SEC Comment Letter 0000000000-23-000462 to China Jo-Jo Drugstores Holdings, Inc. (CJJD) (CIK 0001856084) (RDGT)

China Jo-Jo Drugstores Holdings, Inc. (CJJD) (CIK 0001856084)
Date: Jan. 17, 2023 · CIK: 0001856084 · Accession: 0000000000-23-000462

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-269182

Date

January 17, 2023

Author

Not clearly detected

Form

UPLOAD

Company

China Jo-Jo Drugstores Holdings, Inc. (CJJD) (CIK 0001856084)

Letter

United States securities and exchange commission logo January 17, 2023 Lei Liu Chief Executive Officer China Jo-Jo Drugstores Holdings, Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhejiang Province People’s Republic of China, 310008 Re:China Jo-Jo Drugstores Holdings, Inc. Registration Statement on Form F-3 Filed January 11, 2023 File No. 333-269182 Dear Lei Liu: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cara Wirth at (202) 551-7127 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Elizabeth Chen

Show Raw Text

United States securities and exchange commission logo
January 17, 2023
Lei Liu
Chief Executive Officer
China Jo-Jo Drugstores Holdings, Inc.
Hai Wai Hai Tongxin Mansion Floor 6
Gong Shu District, Hangzhou City, Zhejiang Province
People’s Republic of China, 310008
Re:China Jo-Jo Drugstores Holdings, Inc.
Registration Statement on Form F-3
Filed January 11, 2023
File No. 333-269182
Dear Lei Liu:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Cara Wirth at (202) 551-7127 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:       Elizabeth Chen

SecProbe.io